Stacking the DEK: From chromatin topology to cancer stem cells

por Privette Vinnedge, Lisa M., Kappes, Ferdinand, Nassar, Nicolas, Wells, Susanne I.
Publicado 2013

Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells

por Greene, Allie N., Parks, Lois G., Solomon, Matia B., Privette Vinnedge, Lisa M.
Publicado en Front Mol Neurosci (2020)

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

por Privette Vinnedge, Lisa M., Ho, Shuk-Mei, Wikenheiser-Brokamp, Kathryn A., Wells, Susanne I.
Publicado 2012

The human DEK oncogene stimulates beta catenin signaling, invasion and mammosphere formation in breast cancer

por Privette Vinnedge, Lisa M., McClaine, Rebecca, Wagh, Purnima K., Wikenheiser-Brokamp, Kathryn A., Waltz, Susan E., Wells, Susanne I.
Publicado 2011

Sex Differences in DEK Expression in the Anterior Cingulate Cortex and its Association with Dementia Severity in Schizophrenia

por O’Donovan, Sinead M., Franco-Villanueva, Ana, Ghisays, Valentina, Caldwell, Jody L., Haroutunian, Vahraim, Privette Vinnedge, Lisa M., McCullumsmith, Robert. E., Solomon, Matia B.
Publicado en Schizophr Res (2018)

The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor positive breast cancers

por Privette Vinnedge, Lisa M., Benight, Nancy M., Wagh, Purnima K., Pease, Nicholas A., Nashu, Madison A., Serrano-Lopez, Juana, Adams, Allie K., Cancelas, Jose A., Waltz, Susan E., Wells, Susanne I.
Publicado en Oncogene (2014)

Defects in the Fanconi anemia pathway in head and neck cancer cells stimulate tumor cell invasion through DNA-PK and Rac1 signaling

por Romick-Rosendale, Lindsey E., Hoskins, Elizabeth E., Privette Vinnedge, Lisa M., Foglesong, Grant D., Brusadelli, Marion G., Potter, S. Steven, Komurov, Kakajan, Brugmann, Samantha A., Lambert, Paul F., Kimple, Randall J., Virts, Elizabeth L., Hanenberg, Helmut, Gillison, Maura L., Wells, Susanne I.
Publicado en Clin Cancer Res (2015)